Shots:
- RamSoft Inc. and Therapixel have entered into a commercial partnership to integrate Therapixel’s MammoScreen AI-powered breast imaging software into RamSoft’s PowerServer and OmegaAI platforms
- This collaboration integrates Therapixel’s MammoScreen, breast imaging AI, directly into RamSoft’s platforms
- Recent studies showed that MammoScreen improves radiologist performance with 8% higher sensitivity, 2% higher specificity, and 24% faster readings. It also detected cancers one year prior in 42% and two years prior in 38.5% of time
Ref: Prnewswire| Image: Ramsoft & Therapixel| Press Release
Related News:- CRISPR Therapeutics Enters a Multi-Target Collaboration with Sirius Therapeutics to Develop Novel siRNA Therapies
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
